Target intelligence / Profile preview

PRAME family member 33 (PRAMEF33)

Target
PRAMEF33
Molecular classification
Other (Protein coding gene, PRAME family, predicted Cul2-RING ubiquitin ligase complex component)
01

Overview

PRAME family member 33 (PRAMEF33) is a protein-coding gene that is part of the PRAME gene family, which is generally classified as cancer/testis antigens—genes expressed predominantly in the testis and a variety of cancers. PRAMEF33 is predicted to function as a ubiquitin-like ligase-substrate adaptor within the Cul2-RING ubiquitin ligase complex, likely contributing to proteasome-mediated protein degradation processes in the cytoplasm. However, experimental validation of its functional roles is limited, and unlike the canonical PRAME gene, there is no clear evidence that PRAMEF33 is directly involved in tumorigenesis or is targeted by drugs or immunotherapies. Its expression profile, regulatory mechanisms, and pathogenic relevance remain poorly characterized. It has several aliases, some of which arose from previous gene annotation, but "PRAME family member 33" (PRAMEF33) is the standardized designation. As such, PRAMEF33 is not considered a therapeutic target; rather, it represents a member of a broader gene family with potential—but unverified—biological and disease significance.

Other names
PRAMEF33PRAMEF33PPRAME family member 33PRAME family member 10-likePRAME family member 33, pseudogene
02

Biological functions

Ubiquitin-like ligase-substrate adaptor activity (predicted)Proteasome-mediated ubiquitin-dependent protein catabolic process (predicted)
03

Disease associations

Cancer/testis antigen family (cancer/testis expression profile but direct involvement in disease not demonstrated for PRAMEF33 specifically)No confirmed disease association for PRAMEF33 specifically

Beyond the preview

Go deeper on PRAME family member 33 (PRAMEF33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRAME family member 33 (PRAMEF33).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call